PRF1 and neoplasm: Bispecific antibodies (BsAbs), which have affinities for two different epitopes on tumor cells and specific immune cells like T cells, as a bridge, induce the formation of immunological synapses between T cells and tumor cells, which can make granular enzymes and perforin released by T cells produce lethal effect to the targeted tumor cells (24).